Publications

Detailed Information

Bacteroides fragilis Enterotoxin Induces Human beta-Defensin-2 Expression in Intestinal Epithelial Cells via a Mitogen-Activated Protein Kinase/I kappa B Kinase/NF-kappa B-Dependent Pathway

DC Field Value Language
dc.contributor.authorYoon, Young Mee-
dc.contributor.authorLee, Jin Young-
dc.contributor.authorYoo, Doyoung-
dc.contributor.authorSim, Young-Suk-
dc.contributor.authorOh, Yu-Kyoung-
dc.contributor.authorKim, Sunil-
dc.contributor.authorKim, Jung Mogg-
dc.contributor.authorKim, Joo Sung-
dc.contributor.authorKang, Ju Seop-
dc.contributor.authorKim, Young-Jeon-
dc.date.accessioned2012-06-26T05:28:58Z-
dc.date.available2012-06-26T05:28:58Z-
dc.date.issued2010-05-
dc.identifier.citationINFECTION AND IMMUNITY; Vol.78 5; 2024-2033ko_KR
dc.identifier.issn0019-9567-
dc.identifier.urihttps://hdl.handle.net/10371/77432-
dc.description.abstractEnterotoxigenic Bacteroides fragilis (ETBF) produces an approximately 20-kDa heat-labile enterotoxin (BFT) that plays an essential role in mucosal inflammation. Although spontaneous disappearance of ETBF infection is common, little information is available on regulated expression of antibacterial factors in response to BFT stimulation. This study investigates the role of BFT in human beta-defensin 2 (hBD-2) induction from intestinal epithelial cells. Stimulation of HT-29 and Caco-2 intestinal epithelial cell lines with BFT resulted in the induction of hBD-2. Activation of a reporter gene for hBD-2 was dependent on the presence of NF-kappa B binding sites. In contrast, suppression of AP-1 did not affect hBD-2 expression in BFT-stimulated cells. Inhibition of p38 mitogen-activated protein kinase (MAPK) using SB203580 and small interfering RNA (siRNA) transfection resulted in a significant reduction in BFT-induced I kappa B kinase (IKK)/NF-kappa B activation and hBD-2 expression. Our results suggest that a pathway including p38 MAPK, IKK, and NF-kappa B activation is required for hBD-2 induction in intestinal epithelial cells exposed to BFT, and may be involved in the host defense following infection with ETBF.ko_KR
dc.description.sponsorshipThis work was supported by a National Research Foundation of
Korea (NRF) grant funded by the government of Korea (MEST)
(MRC program no. 2009-0091463) and by the Basic Science Research Program through the NRF funded by the Ministry of Education, Science
and Technology (R11-2008-044-01004-0).
ko_KR
dc.language.isoenko_KR
dc.publisherAMER SOC MICROBIOLOGYko_KR
dc.titleBacteroides fragilis Enterotoxin Induces Human beta-Defensin-2 Expression in Intestinal Epithelial Cells via a Mitogen-Activated Protein Kinase/I kappa B Kinase/NF-kappa B-Dependent Pathwayko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor윤영미-
dc.contributor.AlternativeAuthor이진영-
dc.contributor.AlternativeAuthor유도영-
dc.contributor.AlternativeAuthor심영숙-
dc.contributor.AlternativeAuthor김영전-
dc.contributor.AlternativeAuthor오유경-
dc.contributor.AlternativeAuthor강주섭-
dc.contributor.AlternativeAuthor김선일-
dc.contributor.AlternativeAuthor김주성-
dc.contributor.AlternativeAuthor김정목-
dc.identifier.doi10.1128/IAI.00118-10-
dc.citation.journaltitleINFECTION AND IMMUNITY-
dc.description.citedreferenceKIM JM, 2010, LAB INVEST-
dc.description.citedreferenceWu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015-
dc.description.citedreferenceSears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08-
dc.description.citedreferenceRhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08-
dc.description.citedreferenceKim JM, 2009, CLIN EXP IMMUNOL, V155, P541, DOI 10.1111/j.1365-2249.2008.03849.x-
dc.description.citedreferenceNuding S, 2009, MICROBES INFECT, V11, P384, DOI 10.1016/j.micinf.2009.01.001-
dc.description.citedreferenceLee JY, 2009, J MOL MED-JMM, V87, P169, DOI 10.1007/s00109-008-0415-2-
dc.description.citedreferenceSears CL, 2008, CLIN INFECT DIS, V47, P797, DOI 10.1086/591130-
dc.description.citedreferenceKim JM, 2008, EUR J IMMUNOL, V38, P2190, DOI 10.1002/eji.200838191-
dc.description.citedreferenceGiesemann T, 2008, GASTROENTEROLOGY, V134, P2049, DOI 10.1053/j.gastro.2008.03.008-
dc.description.citedreferenceKim JM, 2008, LAB INVEST, V88, P541, DOI 10.1038/labinvest.2008.16-
dc.description.citedreferenceHale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951-
dc.description.citedreferenceLee JY, 2007, J MOL MED-JMM, V85, P1393, DOI 10.1007/s00109-007-0237-7-
dc.description.citedreferenceKim JM, 2007, INFECT IMMUN, V75, P3373, DOI 10.1128/IAI.01940-06-
dc.description.citedreferenceWehkamp J, 2007, CURR OPIN GASTROEN, V23, P32-
dc.description.citedreferenceKim JM, 2006, EUR J IMMUNOL, V36, P2446, DOI 10.1002/eji.200535808-
dc.description.citedreferenceCash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119-
dc.description.citedreferenceToprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x-
dc.description.citedreferenceWehkamp K, 2006, J INVEST DERMATOL, V126, P121, DOI 10.1038/sj.jid.5700020-
dc.description.citedreferenceDe Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5-
dc.description.citedreferenceKim JM, 2005, EUR J IMMUNOL, V35, P2648, DOI 10.1002/eji.200526321-
dc.description.citedreferenceSchneider JJ, 2005, J MOL MED-JMM, V83, P587, DOI 10.1007/s00109-005-0657-1-
dc.description.citedreferenceSahl HG, 2005, J LEUKOCYTE BIOL, V77, P466, DOI 10.1189/jlb.0804452-
dc.description.citedreferenceWehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004-
dc.description.citedreferenceWu SG, 2004, INFECT IMMUN, V72, P5832, DOI 10.1128/IAI.72.10.5832-5839.2004-
dc.description.citedreferenceBasset C, 2004, DIGEST DIS SCI, V49, P1425-
dc.description.citedreferenceChio CC, 2004, CELL SIGNAL, V16, P565, DOI 10.1016/j.cellsig.2003.10.003-
dc.description.citedreferenceHowell SJ, 2003, PEPTIDES, V24, P1763, DOI 10.1016/j.peptides.2003.07.028-
dc.description.citedreferencePark KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200-
dc.description.citedreferenceTollin M, 2003, PEPTIDES, V24, P523, DOI 10.1016/S0196-9781(03)00114-1-
dc.description.citedreferenceKIM JM, 2003, AM J PHYSIOL-GASTR L, V285, P1171-
dc.description.citedreferenceKim JM, 2002, CLIN EXP IMMUNOL, V130, P59-
dc.description.citedreferenceKrisanaprakornkit S, 2002, J IMMUNOL, V168, P316-
dc.description.citedreferenceKim JM, 2001, CLIN EXP IMMUNOL, V123, P421-
dc.description.citedreferenceWada A, 2001, CELL MICROBIOL, V3, P115-
dc.description.citedreferencePrindiville TP, 2000, EMERG INFECT DIS, V6, P171-
dc.description.citedreferenceKim JM, 2000, SCAND J INFECT DIS, V32, P643-
dc.description.citedreferenceO`Neil DA, 1999, J IMMUNOL, V163, P6718-
dc.description.citedreferenceWada A, 1999, BIOCHEM BIOPH RES CO, V263, P770-
dc.description.citedreferenceZhang GM, 1999, CLIN INFECT DIS, V29, P590-
dc.description.citedreferenceElewaut D, 1999, J IMMUNOL, V163, P1457-
dc.description.citedreferenceBals R, 1999, INFECT IMMUN, V67, P3542-
dc.description.citedreferenceKim JM, 1997, SCAND J IMMUNOL, V45, P613-
dc.description.citedreferenceNiyogi SK, 1997, INDIAN J MED RES, V105, P167-
dc.description.citedreferenceEckmann L, 1996, J IMMUNOL, V156, P2894-
dc.description.citedreferenceBROWN PH, 1993, ONCOGENE, V8, P877-
dc.description.citedreferenceMYERS LL, 1987, AM J VET RES, V48, P774-
dc.description.tc6-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share